As revealed in the datasets of cancer genomic projects [22], MGLL amplification is common in various tumor types such as prostatic carcinomas with neuroendocrine phenotypes [23] and pancreatic ductal adenocarcinomas [24]. Here, MGLL is linked to cancer.